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mostly hypotension and tachycardia, were few. The
incidence of dyskinesia and extrapyramidal side effects
was also surprisingly low—0.4% in the 25 mg group
and 0.8% in the 50 mg group (number needed to harm
156 for both doses).
Newer drugs such as 5-HT3 antagonists have
undoubtedly improved outcomes; a neurokinin recep-
tor antagonist (aprepitant) has also been introduced in
the UK for the treatment of chemotherapy induced
nausea and vomiting.8 However, the mechanism
underlying postoperative nausea and vomiting is so
complex that a universal panacea is unlikely, and a
multimodal approach is best for both prevention and
treatment. In this regard, the optimum dose of
metoclopramide combined with dexamethasone offers
another option for prevention of nausea and vomiting
or as an adjunct or alternative to existing treatment.
A head to head trial of metoclopramide and
dexamethasone versus a 5-HT3 antagonist combined
with dexamethasone would be the next logical step. In
the meantime, the trial by Wallenburg et al supports
metoclopramide as an option for the prevention and
treatment of postoperative nausea and vomiting. This
use of metoclopramide would probably result in
considerable cost saving compared with the newer
5-HT3 antagonists, such as palonosetron, despite their
longer duration of action.
Finally, Wallenborn and colleagues also found that
regular consumption of alcohol protects against
postoperative nausea and vomiting. This finding adds
to the debate about why certain factors, such as smok-
ing, protect against postoperative nausea and vomit-
ing.5
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Heat waves and health protection
Focus on public health, social care, and building regulations
This summer Europe has again been affected bya major heat wave and England triggered itsheat wave response plan for the first time.1 In
2003, the impact of the heat wave in central France was
unprecedented, with more than 14 000 excess deaths
attributed to the 20 day event.2 This year, France has
reported considerably fewer deaths, and the authorities
can claim some credit for effective public health inter-
vention. The United Kingdom experienced a more
severe heat wave than in 2003, but the full impact on
health is not yet known. Schools, offices, hospitals, and
the transport infrastructure were all affected badly.
Although much is known about the regulation of body
temperature in healthy fit adults, little research has
been undertaken on the social and environmental
determinants of heat related mortality. People with
psychiatric disorders, depression, cardiovascular and
cerebrovascular conditions,3 and diabetes4 are at high
risk of death during a heat wave. Specific drugs, such as
neuroleptics and anticholinergics, can also impair
thermoregulation.1 Susceptible people may be socially
isolated and may have a mental illness or disability that
limits their ability to care for themselves. The
perception of ambient temperature is also poorer in
elderly people, who do not always realise that they are
becoming too hot.5 The passive dissemination of
advice on heat avoidance is insufficient for health pro-
tection, and vulnerable people need to be actively
identified and cared for.6
Public health measures implemented in Europe
after 2003 have centred almost exclusively on heat
health warning systems that forecast high risk weather
conditions to trigger public warnings.7 Level 3 of the
heat wave plan for England, triggered in early July,
requires primary care trusts to “Commission addi-
tional care and support, involving at least daily contact,
as necessary for at-risk individuals living at home.” But
there is much confusion about identifying people at
risk as well as the specific advice to be given. Cities in
Italy are the most advanced in identifying and contact-
ing vulnerable people at home during a heat wave. So
far, no heat health system has been formally evaluated,
and the effectiveness of individual interventions is
unknown.6
The impact of heat waves also reveals important
lessons about the care of the elderly and dispossessed
in our society—in both the community and social care.
The impact of heat waves in the United States is mostly
confined to poor elderly people living in urban areas—
who cannot afford air conditioning—and to the home-
less. Elderly people in nursing and residential homes
are more frail than those living independently or with
family. Although such people have a higher risk of
death than the general population, they should not
have a higher risk of heat related death. Heat illness
can be prevented by keeping the patient cool, hydrated,
and with adequate salt balance. In the UK, air
conditioning is rare in clinical settings, and hospital
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inpatients may also be exposed to high indoor
temperatures and a high risk of heatstroke.8
One of the striking things about the heat wave in
France in 2003 was that the high mortality was not
detected for so long. In the UK, several indicators of
heat morbidity are nowmonitored routinely using data
from GP practices and NHS Direct. However, many
countries in Europe, including the UK, do not have
rapid access to mortality data from their registration
systems. Some cities have solved this by bypassing the
official system to get data directly from funeral homes
within 24-48 hours.
The Euroheat network,9 coordinated by the World
Health Organization in Rome, and funded by the
European Commission, is developing good practice
for health protection during heat waves as more coun-
tries develop heat health warning systems. An
inter-agency approach—involving key health and
social care providers as well as stakeholder groups—is
needed. Heat wave systems also need to be better inte-
grated within the disaster response agencies.
Much heat related mortality occurs outside of
defined “heat wave” events.10 The best health
protection measures are those that ensure long term
changes in behaviour, such as the training of staff and
carers and the development of appropriate care stand-
ards in residential homes (as has been implemented in
Hessen, Germany9). Heat stress is also an occupational
health problem for indoor and outdoor workers, and
health and safety agencies need to be prepared for the
impact of hotter summers. London’s mayor is being
particularly proactive with regard to climate change
and is developing a statutory adaptation strategy to
ensure that the infrastructure is appropriate for future
climates. Climate change needs to be taken into
account in health protection in Europe.11 The UK has
recently had its hottest month since records began in
1660.12 The effects of climate change are appearing
earlier than anticipated. It would be tragic if the main
response to hotter summers is to install inefficient air
conditioning and to miss the opportunity to develop
effective and more equitable health protection
measures for extreme weather.
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Governance of research that uses identifiable
personal data
Will improve if the public and researchers collaborate to raise standards
Information contained in routine medical records,disease registries, completed trials, and researchprogrammes is an invaluable resource for research
into public health. The secondary use of such data,
which were often collected for unrelated purposes, has
demonstrated the late effects of treatment, indicated
social differences in health care, suggested environ-
mental causes of cancer, and identified epidemics. For
years the United Kingdom has been in the forefront of
this research, and the NHS has been a unique source of
such data.
In most medical research, doctors and investigators
have direct contact with patients and can seek spoken
and written consent directly. But research reusing pre-
viously collected data may encounter considerable dif-
ficulties with respect to both consent and anonymity.
The study populations may comprise many thousands
of people; some patients will have moved or died; the
information may need to be linked to two or more
databases; and individual identification may be
necessary to prevent double counting. Problems may
arise regarding the necessity and practicability of
obtaining consent, the degree to which the data can be
anonymised without losing vital information, and the
security of the data at all stages.
Such difficulties concerning this secondary use of
identifiable data are now damaging our population
based research—an “own goal” at a time when a
national system of health records would give us
unequalled opportunities for research to improve
health. A series in the BMJ, which ends this week, has
highlighted these problems and suggested solutions.1–4
A recent report from the Academy of Medical Sciences
also provided an analysis and suggested ways forward.5
The problems arise from changes in the law and
their interpretation by regulators, and from increasing
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